TrialProstaglandins, leukotrienes, and essential fatty acids2021

Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation.

Stefania Lamon-Fava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.